Eye-Related Emergency Department Visits and The Opioid Epidemic: a 10-Year Analysis

References

• Kuehn BM. Prescription drug abuse rises globally. Jama. 2007;297(12):1306. doi:10.1001/jama.297.12.1306.
   PubMed Web of Science ®Google Scholar
• Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006;81(2):103–107. doi:10.1016/j.drugalcdep.2005.05.009.
   PubMed Web of Science ®Google Scholar
• Hughes AA, Bogdan GM, Dart RC. Active surveillance of abused and misused prescription opioids using poison center data: a pilot study and descriptive comparison. Clin Toxicol (Phila). 2007;45(2):144–151. doi:10.1080/15563650600981137.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Unintentional poisoning deaths – United States, 1999-2004. MMWR Morb Mortal Wkly Rep. 2007;56(5):93–96.
   PubMedGoogle Scholar
• Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006;15(9):618–627. doi:10.1002/pds.v15:9.
   PubMed Web of Science ®Google Scholar
• Van Handel MM, Rose CE, Hallisey EJ, et al. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr. 2016;73(3):323–331. doi:10.1097/QAI.0000000000001098.
   PubMed Web of Science ®Google Scholar
• Zibbell JE, Asher AK, Patel RC, et al. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018;108(2):175–181. doi:10.2105/AJPH.2017.304132.
   PubMed Web of Science ®Google Scholar
• Tortu S, McMahon JM, Pouget ER, Hamid R. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Substance Use & Misuse. 2004;39(2):211–224. doi:10.1081/JA-120028488.
   PubMed Web of Science ®Google Scholar
• McMahon JM, Tortu S. A potential hidden source of hepatitis C infection among noninjecting drug users. J Psychoactive Drugs. 2003;35(4):455–460. doi:10.1080/02791072.2003.10400492.
   PubMed Web of Science ®Google Scholar
• Hartman L, Barnes E, Bachmann L, Schafer K, Lovato J, Files DC. Opiate injection-associated infective endocarditis in the southeastern United States. Am J Med Sci. 2016;352(6):603–608. doi:10.1016/j.amjms.2016.08.010.
   PubMed Web of Science ®Google Scholar
• Wang Z, Lenehan B, Itshayek E, et al. Primary pyogenic infection of the spine in intravenous drug users: a prospective observational study. Spine (Phila Pa 1976). 2012;37(8):685–692. doi:10.1097/BRS.0b013e31823b01b8.
   PubMed Web of Science ®Google Scholar
• Ziu M, Dengler B, CorDell D, Bartanusz V. Diagnosis and management of primary pyogenic spinal infections in intravenous recreational drug users. Neurosurg Focus. 2014;37(2):E3. doi:10.3171/2014.6.FOCUS14148.
   PubMed Web of Science ®Google Scholar
• Wallen TJ, Szeto W, Williams M, et al. Tricuspid valve endocarditis in the era of the opioid epidemic. J Card Surg. 2018;33(5):260–264. doi:10.1111/jocs.v33.5.
   PubMed Web of Science ®Google Scholar
• Larson MD. Mechanism of opioid-induced pupillary effects. Clin Neurophysiol. 2008;119(6):1358–1364. doi:10.1016/j.clinph.2008.01.106.
   PubMed Web of Science ®Google Scholar
• Tirpack AR, Duker JS, Baumal CR. An outbreak of endogenous fungal endophthalmitis among intravenous drug abusers in New England. JAMA Ophthalmol. 2017;135(6):534–540. doi:10.1001/jamaophthalmol.2017.0650.
   PubMed Web of Science ®Google Scholar
• U.S. Department of health and human services national healthcare quality and disparities report and 5th anniversary update on the national quality strategy. https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/nhqdr15/2015nhqdr.pdf. Accessed November 28, 2018
   Google Scholar
• Elixhauser AHK, Owens PL Healthcare Cost And Utilization Project (HCUP) recommendations for reporting trends using ICD-9-CM and ICD-10-CM/PCS data. https://www.hcup-us.ahrq.gov/datainnovations/HCUP_RecomForReportingTrends_070517.pdf. Accessed August 7, 2018.
   Google Scholar
• Rowe C, Vittinghoff E, Santos GM, et al. Performance measures of diagnostic codes for detecting opioid overdose in the emergency department. Acad Emerg Med. 2017;24(4):475–483. doi:10.1111/acem.13121.
   PubMed Web of Science ®Google Scholar
• Reardon JM, Harmon KJ, Schult GC, Staton CA, Waller AE. Use of diagnosis codes for detection of clinically significant opioid poisoning in the emergency department: a retrospective analysis of a surveillance case definition. BMC Emerg Med. 2016;16(1):11. doi:10.1186/s12873-016-0075-4.
   PubMedGoogle Scholar
• Ellison J, Walley AY, Feldman JA, et al. Identifying patients for overdose prevention with ICD-9 classification in the emergency department, Massachusetts, 2013-2014. 433021. 2016;131(5):671–675. doi:10.1177/0033354916661981.
   Google Scholar
• Russell JF, Scott NL, Hinkle JW, et al. Endogenous endophthalmitis: has the opioid crisis impacted the rates and severity of intravenous drug-related cases? J Vitreoretin Dis. 2018;2(5):262–271. doi:10.1177/2474126418788498.
   Google Scholar
• Iftikhar M, Junaid N, Lemus M, et al. Epidemiology of primary ophthalmic inpatient admissions in the United States. Am J Ophthalmol. 2018;185:101–109. doi:10.1016/j.ajo.2017.10.014.
   PubMed Web of Science ®Google Scholar
• HCUP. NEDS Description of Data Elements. Rockville, MD: HCUP, AHRQ. [Accessed December 19, 2018]. www.hcup-us.ahrq.gov/db/nation/neds/nedsdde.jsp.
   Google Scholar
• HCUP. NEDS Overview. Rockville, MD: AHRQ. [Accessed October, 2018]. www.hcup-us.ahrq.gov/nedsoverview.jsp.
   Google Scholar
• U.S. Department of Health and Human Services AHRQ Publication 2016. 2015 National Healthcare Quality and Disparities Report and 5th anniversary update on the national quality strategy. AHRQ Publication No. 16-0015. Rockville, MD: Agency for Healthcare Research and Quality; 2016. https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/nhqdr15/2015nhqdr.pdf. Accessed November 24, 2018.
   Google Scholar
• Tielsch JM, Parver LM. Determinants of hospital charges and length of stay for ocular trauma. Ophthalmology. 1990;97(2):231–237. doi:10.1016/S0161-6420(90)32600-3.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8.
   PubMedGoogle Scholar
• Substance Abuse and Mental Health Services Administration. DAWN Series D-25, DHHS Publication No.(SMA) 04-875 (2004). Mortality Data from the Drug Abuse Warning Network. 2002.
   Google Scholar
• Viestenz A, Küchle M. Retrospective analysis of 417 cases of contusion and rupture of the globe with frequent avoidable causes of trauma: the Erlangen Ocular Contusion-Registry (EOCR) 1985-1995. Klin Monatsbl Augenh. 2001;218(10):662–669.doi:10.1055/s-2001-18388.
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Inciardi JA, Munoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain. 2005;6(10):662–672. doi:10.1016/j.jpain.2005.05.004.
   PubMed Web of Science ®Google Scholar
• Rollins MD, Feiner JR, Lee JM, Shah S, Larson M. Pupillary effects of high-dose opioid quantified with infrared pupillometry. Anesthesiology. 2014;121(5):1037–1044. doi:10.1097/ALN.0000000000000384.
   PubMed Web of Science ®Google Scholar
• Rottach KG, Wohlgemuth WA, Dzaja AE, Eggert T, Straube A. Effects of intravenous opioids on eye movements in humans: possible mechanisms. J Neurol. 2002;249(9):1200–1205. doi:10.1007/s00415-002-0806-1.
   PubMed Web of Science ®Google Scholar
• Murray RB, Adler MW, Korczyn AD. The pupillary effects of opioids. Life Sci. 1983;33(6):495–509. doi:10.1016/0024-3205(83)90123-6.
   PubMed Web of Science ®Google Scholar
• Drago F, Panissidi G, Bellomio F, Belle AD, Aguglia E, Gorgone G. Effects of opiates and opioids on intraocular pressure of rabbits and humans. Clin Exp Pharmacol Physiol. 1985;12(2):107–113. doi:10.1111/cep.1985.12.issue-2.
   PubMed Web of Science ®Google Scholar
• Wesson DR, Ling W. The clinical opiate withdrawal scale (COWS). J Psychoactive Drugs. 2003;35(2):253–259. doi:10.1080/02791072.2003.10400007.
   PubMed Web of Science ®Google Scholar
• Iftikhar M, Latif A, Farid UZ, Usmani B, Canner JK, Shah SMA. Changes in the incidence of eye trauma hospitalizations in the United States from 2001 through 2014. JAMA Ophthalmol. 2019;137(1):48–56. doi:10.1001/jamaophthalmol.2018.4685.
   PubMed Web of Science ®Google Scholar
• Senra H, Barbosa F, Ferreira P, et al. Psychologic adjustment to irreversible vision loss in adults: a systematic review. Ophthalmology. 2015;122(4):851–861. doi:10.1016/j.ophtha.2014.10.022.
   PubMed Web of Science ®Google Scholar
• Senra H, Vieira CR, Nicholls EG, et al. Depression and experience of vision loss in group of adults in rehabilitation setting: mixed-methods pilot study. J Rehabil Res Dev. 2013;9:50.
   Google Scholar
• Abraham HD, Fava M. Order of onset of substance abuse and depression in a sample of depressed outpatients. Compr. 1999;40:44–50.
   PubMed Web of Science ®Google Scholar
• Unick GJ, Rosenblum D, Mars S, Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009. PLoS One. 2013;8(2):e54496. doi:10.1371/journal.pone.0054496.
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 2015;373(18):1789–1790. doi:10.1056/NEJMc1505541.
   PubMed Web of Science ®Google Scholar